Molineaux and Bradbury on board at Geron
This article was originally published in Scrip
Executive Summary
Geron has appointed Dr Susan Molineaux and Daniel Bradbury to its board of directors. Dr Molineaux is currently CEO and president of Calithera Biosciences which she co-founded in June 2010. Mr Bradbury previously served as CEO of Amylin Pharmaceuticals until its acquisition by Bristol-Myers Squibb in August 2012. He is currently on the boards of Illumina and Castle Biosciences.